Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Avacta Group PLC (AVCT)

London
Currency in GBP
Disclaimer
44.72
-0.38(-0.84%)
Real-time Data

AVCT Price Commentary

This silence has gone on to long ,time let long suffering shareholders the o
check yahoo finance profile ;-)
Ouch. 50p
Its all about the AVA
Anyone else just think Avacta have had 2 years to get a test out yet how did all the Chinese tests got there a year and a half earlier?
and how are the Chinese test kits testing for the new variants that keep coming?
Its called “corruption”.
seems they're finally getting their comeuppance
Or even ********
ETF!
UK demand alone for 'accurate' & easy to perform rapid lateral flow tests is apparently running at c. 1.8m units/day. Thus hypothetically at say £5 each, that's a revenue run-rate (whilst schools are open) of £9m/day, or >£200m/month. Not bad news for the likes of Avacta, Omega Diagnostics & Abingdon health, along with PCR testing firms such as Novacyt & SourceBio Internationa, who should also benefit from extra 'knock-on' confirmatory volume having to be performed by their mobile/fixed labs.
All coming speedily to fruition, with regard to the covid test’s. The cash gsnerated will fund th Ed cancer side. This will bs the major bread winner. Of course after a future Nasdaq quoute, this will most likely lead to a take out by sons big pharma. Buy now, in the next 3 weeks this share will be much higher, imo
why such a bounce? now back to where it was 2 days ago
FOMO Friday
am l the only one thinks once the manufacturing details are released this will go to at least £4? With the LFT printing money every second for the next year at least, a buyback, special dividend or takeover has to be on the cards, likely the later given the start of that ava6000 cancer therapy trials.
buy and hold...as the new spread re the tests it should boost price further.
This will be sales of LFT test kits in the UK, then Europe and even world wide could follow, so it could go much higher, 👍
Avacta have the best rapid antigen test going. Only one way from here...
SP finally going down. CEO has a nice house from the sale proceeds
CEO sold some of his holding. So? Guess he could have sold out completely if he had no faith.
https://www.gov.uk/government/news/government-invests-in-uk-developed-antibody-tests-from-uk-rapid-test-consortium
6th October old news??
Take a look at ODX, Omega Diagnostics Limited. Part of the consortium for UK-RTC. Abingdon have been awarded a 75m conteact today and 25% of it will go to Omega. The other 2 companies in the consortium are not listed. You can imagine the potentional. So far 717% rise. You can do your research to verify the above, but you’ll not be dissapointed.
too many parties involved . of the £75m divide by 2 to get costs out of the way. then divide by 4. profit =£9m.odx looks fairly valued here. if there were not any other parties involved it would be an easy buy.
There is going to be a huge demand for test kits during this winter
yes but UK government has chosen a different company
Yep, they have. Take a look at ODX, Omega Diagnostics Limited. Part of the consortium for UK-RTC. Abingdon have been awarded a 75m conteact today and 25% of it will go to Omega. The other 2 companies in the consortium are not listed. You can imagine the potentional. So far 717% rise. You can do your research to verify the above, but you’ll not be dissapointed.
which company are you reffering to? Abingdon?
Anyone know the reason for the sudden drop?
Future FTSE 100 company written all over it.
solid company with an amazing future ahead CEO is on the ball and has a good buisness mind,can see avacta becoming a massive company in 5-10 years
I can see this stock going for £5 a share down the line.
Read Myles McNulty’s 24/6 uodate re valuation..intresring read.
I think this stock will do very well, it has lots of day traders so that is making it move up and down, but think this has 250 plus even by end of year. company is working hard and many bits of news can follow.
what's peoples opinions on this stock? I bought them at 125
looks like a good entry point?
Just people flitting from one covid stock to another, this one to hold for a while.. it will go up and down but in the end this will be there when the rest fall away. It's not a one trick pony.
Not sure with this now, looks like it’s stalled. Profit taking maybe?
Connifer investment and profile of their business tells you everything, only invested in £bn buisnesses amd ... a small Mcap on aim... they are not here for £30m...
To update, been looking more into this. With ongoing projects alone it is worth almost 666mil. Wow. The pre|CISION for cancer has the “potential” to make 1.2bil.
Kalpit..Avacta have many other options and partners without the Covid drama... With what they have they could end up a multi billion pound company.In a year or two it could have an SP of £5 to £10
Company value around 350mil. Mk cap now bit over.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.